SpecialtiesQuestion

How frequently or soon have you noticed TNF-a induced psoriasiform dermatitis develop?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

How do you approach management of a patient with coexisting psoriasis and systemic sclerosis, particularly when both active psoriasis and skin tightening are present?

Would oral roflumilast be a reasonable and tolerable option for severe psoriasis in an elderly patient with a history of pulmonary aspergillosis who has failed other systemic therapies?

Would you stop bimekizumab in a patient who has severe psoriasis and has responded well to this therapy but is found to have newly diagnosed cirrhosis?

How do you feel the oral IL-23 (Icotyde) will shape psoriasis management?

When managing pediatric psoriasis patients who have achieved stable remission on systemic therapies, how do you approach tapering or stopping therapy?

Evidence Meets Expertise

Community

Browse Specialties
Code of Conduct
AI Community Guidelines

Tools

Mednet AI
Mobile App

Company

About
Careers
Our Work
Blog

Support

FAQs
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.